Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1645 1651 1657
This examiner grants 83% of resolved cases
Bonirath Chhay serves as a patent examiner in Art Unit 1645 within Tech Center 1600. The current data set for this examiner includes 6 resolved cases. Among these resolutions, the allowance rate is 83.3 percent. This percentage indicates a high frequency of grants for the limited number of applications that have reached a final disposition.
The interview lift is recorded at 0.0 percent. This figure shows that for the 6 resolved cases, an interview did not result in an increase over the 83.3 percent allowance rate. Practitioners should note that with a small sample size, the impact of interviews may not yet be fully reflected in the statistical record for this examiner.
The median days to allowance for applications under this examiner is 1175. This duration represents the time required to move from filing to a patent grant in Art Unit 1645. While the 1175 days to allowance is a specific metric, it is based on the small volume of 6 cases currently resolved in Tech Center 1600.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19144202 | MICROORGANISMS INTRODUCED WITH EXOGENOUS SOLUBLE PYRIDINE NUCLEOTIDE TRANSHYDROGENASE AND METHOD FOR PRODUCING L-TRYPTOPHAN USING THE SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18860177 | OSMOLYSIS-BASED RECOVERY OF BIOMACROMOLECULES FROM ENGINEERED HALOTOLERANT MICROORGANISMS | Non-Final OA | The Regents of the University of California |
| 18681457 | GENETICALLY ENGINEERED CELL-DERIVED VACCINES | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18247084 | METHODS FOR REDUCING HOST CELL PROTEIN CONTENT IN PROTEIN PURIFICATION PROCESSES | Final Rejection | Eli Lilly and Company |
| 18557721 | METHODS FOR THE ADMINISTRATION OF ADAMTS BINDING IMMUNOGLOBULINS | Final Rejection | Sanofi |
| 18286030 | OFATUMUMAB FOR TREATING MULTIPLE SCLEROSIS IN ASIAN PATIENTS | Non-Final OA | Novartis AG |
| 18582346 | COMPOSITIONS AND METHODS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY BIOMARKER DETECTION | Non-Final OA | University of Washington |
| 18285920 | A MULTIPLEX ASSAY FOR THE DIAGNOSIS OF BRUCELLA CANIS INFECTION | Non-Final OA | CORNELL UNIVERSITY |
| 18844433 | IMMUNOGENIC COMPOSITIONS | Non-Final OA | GLAXOSMITHKLINE BIOLOGICALS SA |
| 18553229 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING GASTROINTESTINAL INFLAMMATION | Final Rejection | DUPONT NUTRITION BIOSCIENCES APS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy